Neuroimaging bei Aufmerksamkeitsdefizit/Hyperaktivitätsstörung (ADHS)

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Dr. Thomas Vanicek

Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien


Koautoren: Dr. Alexander Kautzky, Dr. Marie Spies, Dr. Konstantinos Papageorgiou, Assoc.-Prof. Priv.-Doz. Dr. Rupert Lanzenberger, o. Univ.-Prof. Dr. Dr. h. c. Siegfried Kasper

Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien


1 Volkow ND, Swanson JM, Clinical practice: Adult attention deficit-hyper­activity disorder. N Engl J Med 2013; 369(20):1935–1944
2 Del Campo N et al., The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 2011; 69(12):e145–157
3 Willcutt E et al., Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005; 57(11):1336–1346
4 Lijffijt M, et al., A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: deficient inhibitory motor control? Journal of abnormal psychology 2005; 114(2):216–222
5 Bush G, Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology 2010; 35:278–300
6 Berridge CW et al., Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006; 60(10):1111–1120
7 Bymaster FP et al., Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002; 27(5):699–711
8 Chamberlain SR et al., Atomoxetine modulates right inferior frontal acti­vation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry. 2009; 65(7):550–555
9 Castells X et al., Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS drugs. 2011; 25(2):157–169
10 Krause KH et al., Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neuroscience letters 2000; 285(2):107–110
11 Dresel S et al., Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 2000; 27(10):1518–1524
12 Volkow ND et al., Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007; 34(3):1182–1190
13 Volkow ND et al., Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA: the journal of the American Medical Association 2009; 302(10):1084–1091
14 del Campo N et al., A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. Brain 2013; 136(Pt 11):3252–3270
15 Vanicek T et al., The Norepinephrine Transporter in Attention-Deficit/Hyperactivity Disorder Investigated With Positron Emission Tomography. JAMA Psychiatry 2014 Dec 1; 71(12):1340–9
16 Frodl T, Skokauskas N, Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta psychiatrica Scandinavica 2012; 125(2):114–126
17 Shaw P et al., Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006; 63(5):540–549
18 Konrad K, Eickhoff SB, Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp. Jun 2010; 31(6):904–916
19 Cortese S et al., Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 2012; 169(10):1038–1055
20 Rubia K, Alegria A, Brinson H, Imaging the ADHD brain: disorder-specificity, medication effects and clinical translation. Expert review of neurotherapeutics 2014; 14(5):519–538
21 Smith A et al., Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination. Biol Psychiatry 2013; 74(8):615–622
22 Gusnard DA, Raichle ME, Raichle ME, Searching for a baseline: functional imaging and the resting human brain. Nature reviews. Neuroscience 2001; 2(10):685–694
23 Durston S. Imaging genetics in ADHD. Neuroimage 2010; 53(3):832–838
24 Gilsbach S et al., Effects of the DRD4 genotype on neural networks associated with executive functions in children and adolescents. Developmental cognitive neuroscience 2012; 2(4):417–427
25 Hong SB et al., COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder. Hum Brain Mapp 2014

SP 04|2014

Herausgeber: Univ.-Prof. Dr. Michael Musalek
Publikationsdatum: 2014-12-22